Brian G. Atwood - 30 May 2025 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
Director
Signature
/s/ Andrew Kucharchuk, Attorney-in-Fact
Issuer symbol
CERO
Transactions as of
30 May 2025
Net transactions value
$0
Form type
4
Filing time
02 Jun 2025, 17:02:49 UTC
Previous filing
04 Apr 2025
Next filing
09 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ATWOOD BRIAN G Director CERO THERAPEUTICS HOLDINGS, INC., 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO /s/ Andrew Kucharchuk, Attorney-in-Fact 02 Jun 2025 0001266567

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERO Stock Option (Right to Buy) Award $0 +122,549 $0.000000 122,549 30 May 2025 Common Stock 122,549 $0.4454 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in equal monthly installments through May 30, 2027.

Remarks:

Exhibit 24 - Power of Attorney.